Coelingh Bennink, Herjan J. T.
Schultz, Iman J.
Schmidt, Marcus
Jordan, V. Craig
Briggs, Paula
Egberts, Jan F. M.
Gemzell-Danielsson, Kristina
Kiesel, Ludwig
Kluivers, Kirsten
Krijgh, Jan
Simoncini, Tommaso
Stanczyk, Frank Z.
Langer, Robert D.
Article History
Received: 1 February 2023
Accepted: 22 May 2023
First Online: 30 May 2023
Declarations
:
: Not applicable.
: Not applicable.
: HJTCB is President, IJS is Director R&D and JK is Chief Medical Officer of Pantarhei Oncology (subsidiary of Pantarhei Bioscience), the company developing the fetal estrogen estetrol for the treatment of advanced breast and prostate cancer, but this is outside the scope of the present review. The other authors have nothing to disclose.